APSO has released its finalized tinnitus evaluation standard while opening a complementary tinnitus treatment and management standard for public review to advance evidence-based audiology practice.
In addition to her current responsibilities for corporate development and strategy, Ms Tully will now assume responsibility for all of Neuromod’s operating activities, including manufacturing, supply chain, regulatory, quality, and compliance functions. Ms Tully will continue to report to Dr Ross O’Neill, Chief Executive Officer of Neuromod.
The need for helping patients who have tinnitus is enormous, and our capacity to meet their needs is still finite. However, just because we don't know all of the answers doesn't relieve us from asking important questions and doing what we can in providing relief for patients with tinnitus.